GlassScriptPhysician profile
Ahmad A Hadid
NPI 1558364414
$1,837.28
in general payments reported to CMS, 2019-2025
13 companies · $160 in 2025
The $160 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $452 · 2020: $94.54 · 2021: $468 · 2022: $143 · 2023: $44.01 · 2024: $475 · 2025: $160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $679.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $678.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $545.78 | 2019-2022 | |
| Boston Scientific Corporation | $297.32 | 2019-2025 | Avvigo Guidance System |
| Amgen INC. | $249.82 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $173.53 | 2024-2025 | |
| Abbott Laboratories | $159.16 | 2023-2024 | Mitraclip, Amplatzer Amulet |
| Medtronic Vascular, INC. | $123.35 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $121.72 | 2024 | |
| Janssen Pharmaceuticals, INC | $65.91 | 2020-2024 | Xarelto |
| Abiomed | $33.71 | 2025 | |
| Penumbra, INC. | $23.56 | 2024 | Ruby Coil |
| Bard Peripheral Vascular, INC. | $17.78 | 2025 | Powerport M.R.I. Implantable Port |
| Philips North America LLC | $13.49 | 2022 | |
| Pfizer INC. | $12.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ahmad Hadid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.